AlloVir
Why Robinhood?
You can watch AlloVir and buy or sell other stocks, ETFs, and their options commission-free!About ALVR
Kalaris Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing and commercializing innovative therapeutics for retinal diseases. It is focusing on developing TH103, a novel anti-VEGF agent targeted at treating neovascular and exudative retinal diseases.
ALVR Key Statistics
Stock Snapshot
With a market cap of 183.47M, AlloVir(ALVR) trades at $9.81. The stock has a price-to-earnings ratio of -1.35.
On 2026-03-10, AlloVir(ALVR) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 43.84K.
The stock's 52-week range extends from a low of $2.14 to a high of $12.90.
The stock's 52-week range extends from a low of $2.14 to a high of $12.90.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.